Cargando…

Hepatitis D: advances and challenges

Hepatitis D virus (HDV) infection causes the most severe form of viral hepatitis with rapid progression to cirrhosis, hepatic decompensation, and hepatocellular carcinoma. Although discovered > 40 years ago, little attention has been paid to this pathogen from both scientific and public communiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Zhijiang, Xie, Zhenrong, Ren, Li, Pan, Qiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276264/
https://www.ncbi.nlm.nih.gov/pubmed/35234694
http://dx.doi.org/10.1097/CM9.0000000000002011
_version_ 1784745682350899200
author Miao, Zhijiang
Xie, Zhenrong
Ren, Li
Pan, Qiuwei
author_facet Miao, Zhijiang
Xie, Zhenrong
Ren, Li
Pan, Qiuwei
author_sort Miao, Zhijiang
collection PubMed
description Hepatitis D virus (HDV) infection causes the most severe form of viral hepatitis with rapid progression to cirrhosis, hepatic decompensation, and hepatocellular carcinoma. Although discovered > 40 years ago, little attention has been paid to this pathogen from both scientific and public communities. However, effectively combating hepatitis D requires advanced scientific knowledge and joint efforts from multi-stakeholders. In this review, we emphasized the recent advances in HDV virology, epidemiology, clinical feature, treatment, and prevention. We not only highlighted the remaining challenges but also the opportunities that can move the field forward.
format Online
Article
Text
id pubmed-9276264
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-92762642022-07-13 Hepatitis D: advances and challenges Miao, Zhijiang Xie, Zhenrong Ren, Li Pan, Qiuwei Chin Med J (Engl) Review Articles Hepatitis D virus (HDV) infection causes the most severe form of viral hepatitis with rapid progression to cirrhosis, hepatic decompensation, and hepatocellular carcinoma. Although discovered > 40 years ago, little attention has been paid to this pathogen from both scientific and public communities. However, effectively combating hepatitis D requires advanced scientific knowledge and joint efforts from multi-stakeholders. In this review, we emphasized the recent advances in HDV virology, epidemiology, clinical feature, treatment, and prevention. We not only highlighted the remaining challenges but also the opportunities that can move the field forward. Lippincott Williams & Wilkins 2022-04-05 2022-02-28 /pmc/articles/PMC9276264/ /pubmed/35234694 http://dx.doi.org/10.1097/CM9.0000000000002011 Text en Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Review Articles
Miao, Zhijiang
Xie, Zhenrong
Ren, Li
Pan, Qiuwei
Hepatitis D: advances and challenges
title Hepatitis D: advances and challenges
title_full Hepatitis D: advances and challenges
title_fullStr Hepatitis D: advances and challenges
title_full_unstemmed Hepatitis D: advances and challenges
title_short Hepatitis D: advances and challenges
title_sort hepatitis d: advances and challenges
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276264/
https://www.ncbi.nlm.nih.gov/pubmed/35234694
http://dx.doi.org/10.1097/CM9.0000000000002011
work_keys_str_mv AT miaozhijiang hepatitisdadvancesandchallenges
AT xiezhenrong hepatitisdadvancesandchallenges
AT renli hepatitisdadvancesandchallenges
AT panqiuwei hepatitisdadvancesandchallenges